The concept of biosimilars: from characterization to evolution—a narrative review
… We aim to clarify the concept of biosimilar, from … a literature search on the sites of the
medicines regulatory agencies and PubMed from 1990 to 2014 with the keywords “biosimilars,” “…
medicines regulatory agencies and PubMed from 1990 to 2014 with the keywords “biosimilars,” “…
Biosimilars: an update
S Bhojaraj, TDA Kumar, AR Ghosh… - … Journal of Nutrition …, 2021 - journals.lww.com
… efficacy and safety data on biosimilars. This review summarizes the recent updates on
biosimilars, synthesis, characterization, and current market status. Brief information on the role of …
biosimilars, synthesis, characterization, and current market status. Brief information on the role of …
Clinical and regulatory concerns of biosimilars: a review of literature
V Halimi, A Daci, K Ancevska Netkovska… - International journal of …, 2020 - mdpi.com
… To conduct and explore this review, we mainly followed the PRISMA guidelines for systematic
reviews [18], although “state of the art” methodology was also used. To identify relevant …
reviews [18], although “state of the art” methodology was also used. To identify relevant …
[PDF][PDF] Clinical and Regulatory Concerns of Biosimilars: A Review of Literature
A Grozdanova, H Vesa, A Daci… - Int. J. Environ. Res …, 2020 - repository.ukim.mk
… explore this review, we mainly followed the PRISMA guidelines for systematic reviews [18], …
Preferred reporting items for systematic review and meta-analysis protocols (prisma-p) 2015…
Preferred reporting items for systematic review and meta-analysis protocols (prisma-p) 2015…
Adalimumab biosimilars in the treatment of rheumatoid arthritis: a systematic review of the evidence for biosimilarity
TWJ Huizinga, Y Torii, R Muniz - Rheumatology and therapy, 2021 - Springer
… efficacy and safety can clearly be deduced from the similarity of physicochemical
characteristics, biological activity/potency, and PK and/or PD profiles of the biosimilar and the RP. …
characteristics, biological activity/potency, and PK and/or PD profiles of the biosimilar and the RP. …
[PDF][PDF] The complexities of biosimilars and the regulatory approval process
S Lucio - Am J Manag Care, 2018 - ajmc.s3.amazonaws.com
… The designation of biosimilars is defined in relation to a reference product in an FDA
licensure … The concept of biosimilars: from characterization to evolution— a narrative review. …
licensure … The concept of biosimilars: from characterization to evolution— a narrative review. …
Assessment of the differences between generic and biosimilar drugs: a brief literature review
R Sayah, S Awada, L Ismaiil… - Journal of Generic …, 2023 - journals.sagepub.com
… Even though generic drugs and biosimilars are both copies of a reference drug, they differ
… , this short review aims to compare generic drugs and biosimilars in terms of characteristics, …
… , this short review aims to compare generic drugs and biosimilars in terms of characteristics, …
Global acceptance of biosimilars: importance of regulatory consistency, education, and trust
E Cazap, I Jacobs, A McBride, R Popovian… - The …, 2018 - academic.oup.com
… or summaries of product characteristics (SmPCs). In Europe, … systematic review of assessment
reports for biosimilars … and that, even for biosimilars referencing the same originator, there …
reports for biosimilars … and that, even for biosimilars referencing the same originator, there …
[DOC][DOC] Literature Review of International Biosimilar Medicines: Update December 2017–February 2018
M Ward, SR Lange, K Staff, P MPharm - health.gov.au
… during the review period that are of a technical nature and relate to topics such as the
physicochemical and pharmacological characterisation of potential biosimilar medicines. …
physicochemical and pharmacological characterisation of potential biosimilar medicines. …
A bibliometric analysis of the global research on biosimilars
A Hernández-Vásquez, CA Alarcon-Ruiz… - … policy and practice, 2018 - Taylor & Francis
… Biosimilars could be a promising option to help decrease healthcare costs and … analysis
on biosimilars. Therefore, we aimed to assess the quantity and quality of worldwide biosimilars …
on biosimilars. Therefore, we aimed to assess the quantity and quality of worldwide biosimilars …